Please login to view this media
- Talk
- Canada
Survival Differences for Rural and Low-income Soft Tissue Sarcoma Patients in a Country with Universal Healthcare – A 23-year Population-based Study
Description
This presentation delivered by Anthony Bozzo discusses a comprehensive study focused on the survival differences of rural and low-income patients with soft tissue sarcoma in Canada, a nation known for its universal health care system. The research spans 23 years and includes nearly 9,000 biopsy-confirmed soft tissue sarcoma patients. Key to the study was the stratification of survival rates by various factors such as age, cancer stage, and tumor location (whether extremity or axial).
Bozzo emphasizes previous findings indicating discrepancies in survival rates among rural patients in the United States and aims to examine if similar trends exist in Canada despite uniform access to health care resources. The results revealed significant differences in survival rates based on patients' urban or rural location and across income quintiles, challenging the assumption that universal health care would equalize outcomes.
For clinicians, this data provides a more nuanced perspective on survival rates that considers critical prognostic variables, moving beyond the standard five-year survival estimate of 50% to 70%. The presentation also addresses the importance of adjusting for residual confounding variables, suggesting that factors such as the comorbidity index could further explain observed differences in survival. Ultimately, Bozzo calls on health care providers to be mindful of these discrepancies when treating sarcoma patients.